"Designing Growth Strategies is in our DNA"
Diabetic nephropathy is a disease caused by the impairment of the kidney among the patients suffering from diabetes. This disease is characterized by albuminuria, a reduction in the rate of glomerular filtration, and elevated arterial blood pressure. Additionally, damage to small blood vessels also influences the filtration process of the kidney leading to occurrence of the diabetic nephropathy. Diabetic nephropathy is one of the major causes of end-stage renal disease. Furthermore, diabetic nephropathy disease can be diagnosed by urine tests, blood tests, and diagnostic imaging techniques. The prevalence of diabetic nephropathy is majorly seen in patient’s age ranging between 12 or less than 18 years and prevalence rate ranged from 1.62 to 4.30%.
Key Market Driver -
Rising prevalence of diabetes
Key Market Restraint -
Lack of diabetic management and more time consumption for drug approval process
Increasing prevalence of diabetes, rise in geriatric population, rise in chronic diseases, increase in cardiovascular patients and obesity are some of the major factors driving that are positively influencing the growth of the diabetic nephropathy market during the forecast period. For instance, global prevalence of diabetes is about 5% for the age group of 45-49 years, 15% in 55-59 years, and almost about 20% in age group of 65-69 years. Additionally, in 2017, the global diabetic prevalence rate of 8.8% was observed in the age group of 20-75 years. Moreover, an increase in research and development activities related to drug discovery, technological advancements are fueling the demand for the growth of the diabetic nephropathy market in the near future. For instance, technologically advanced urine tests, blood tests, minimally invasive techniques, and combination therapy.
However, lack of skilled professionals, stringent regulations, the dearth of diabetes management, and more time consumption for the drug approval process are hindering the growth of the diabetic nephropathy market.
Globally, the diabetic nephropathy market is segmented on bases of product type, disease type and distribution channels. Based on the product type the market is segmented into calcium channel blockers, diuretics, G protein coupled receptors, antioxidant inflammation modulators, and others. Based on disease type the market is characterized into Class I - Glomerular basement membrane thickening, Class II - mesangial expansion, mild or severe, Class III - nodular sclerosis, and Class IV - advanced diabetic glomerulosclerosis. Based on the distrubution channels, the market is classified into hospitals pharmacies, retail pharmacies, and online pharmacies.
The major companies in the global diabetic nephropathy market report include Merck & Co., Inc., Abbott, Pfizer Inc., Siemens, Novartis AG, GENERAL ELECTRIC COMPANY, Bayer AG, Mitsubishi Tanabe Pharma Corporation., Renata Limited, and others.
To gain extensive insights into the market, Request for Customization
Geographically, diabetic nephropathy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the diabetic nephropathy market owing to the prevalence of diabetes, quick technological adoption, advancement in diagnostic imaging, rise in healthcare awareness and monitoring, and early diagnosis. For instance, National Kidney Disease Education Program (NKDEP) is organized by the government of the U.S., for creating awareness of kidney diseases. Europe is the second-largest contributor due to the rise in healthcare expenditure and increase in healthcare awareness. Asia Pacific is the fastest growing owing to the rise in the geriatric population, an increase in government support for healthcare programs, and a rise in diabetes management.
By Product Type
By Disease Type
By Distribution Channels
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry